Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
USNA Stock Forecast 2026-2027
$18.96
Current Price
$349.94M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to USNA Price Targets
+105.7%
To High Target of $39.00
+105.7%
To Median Target of $39.00
+105.7%
To Low Target of $39.00
USNA Price Momentum
-2.0%
1 Week Change
+3.4%
1 Month Change
-35.7%
1 Year Change
-3.4%
Year-to-Date Change
-50.5%
From 52W High of $38.32
+14.2%
From 52W Low of $16.60
📊 TOP ANALYST CALLS
Did USNA Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if USANA is one of their latest high-conviction picks.
Latest USNA Stock Price Targets & Analyst Predictions
USNA has shown a year-to-date change of -3.4% and a 1-year change of -35.7%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for USNA. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
USNA Analyst Ratings
0
Buy
0
Hold
0
Sell
USNA Price Target Range
Low
$39.00
Average
$39.00
High
$39.00
Current: $18.96
Latest USNA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for USNA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 27, 2025 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $36.00 |
| Jan 2, 2025 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $38.00 |
| Oct 23, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $35.00 |
| Jul 25, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $38.00 |
| May 7, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $46.00 |
| Feb 22, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $48.00 |
| Oct 25, 2023 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $53.00 |
| Apr 26, 2023 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $56.00 |
| Feb 13, 2023 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $52.50 |
| Oct 27, 2022 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $49.00 |
| Jul 28, 2022 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $57.00 |
| Jul 12, 2022 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $58.00 |
| Jul 7, 2022 | Jefferies | Stephanie Wissink | Underperform | Downgrade | $53.00 |
| Apr 27, 2022 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $76.00 |
| Apr 14, 2022 | DA Davidson | Neutral | Initiates | $N/A | |
| Feb 10, 2021 | Roth Capital | David Bain | Buy | Maintains | $126.00 |
| Dec 17, 2020 | Roth Capital | Buy | Initiates | $N/A | |
| Aug 22, 2019 | Jefferies | Hold | Initiates | $N/A | |
| Jul 3, 2019 | Sidoti & Co. | Neutral | Downgrade | $70.00 | |
| Apr 16, 2019 | Tigress Financial | Buy | Initiates | $N/A |
Usana Health Sciences, Inc. (USNA) Competitors
The following stocks are similar to USANA based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Usana Health Sciences, Inc. (USNA) Financial Data
Usana Health Sciences, Inc. has a market capitalization of $349.94M with a P/E ratio of 38.9x. The company generates $925.94M in trailing twelve-month revenue with a 1.0% profit margin.
Revenue growth is +0.3% quarter-over-quarter, while maintaining an operating margin of +5.5% and return on equity of +1.6%.
Valuation Metrics
Market Cap
$349.94M
Enterprise Value
$260.51M
P/E Ratio
38.9x
PEG Ratio
-2.4x
Price/Sales
0.4x
Growth & Margins
Revenue Growth (YoY)
+0.3%
Gross Margin
N/A
Operating Margin
+5.5%
Net Margin
+1.0%
EPS Growth
-20.1%
Financial Health
Cash/Price Ratio
+46.7%
Current Ratio
2.5x
Debt/Equity
2.4x
ROE
+1.6%
ROA
+4.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Usana Health Sciences, Inc. (USNA) Business Model
About Usana Health Sciences, Inc.
What They Do
Develops and distributes nutritional supplements and personal care products.
Business Model
The company operates a direct selling model, which allows it to market its products while empowering entrepreneurs globally. This model enables Usana to reach a wide customer base and generate revenue through the sale of its high-quality vitamins, dietary supplements, and personal care items.
Additional Information
Founded in 1992, Usana emphasizes scientific research and product safety, establishing a strong reputation among health-conscious consumers and professionals. The company is well-positioned in the growing wellness market, reflecting the increasing demand for preventive health and personalized healthcare solutions.
Company Information
Sector
Consumer Defensive
Industry
Packaged Foods
Employees
1,700
CEO
Mr. Jim Brown
Country
United States
IPO Year
1995
Website
www.usana.comUsana Health Sciences, Inc. (USNA) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
USANA Health (USNA) Upgraded to Buy: What Does It Mean for the Stock?
USANA Health (USNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
May 08, 2026
By Zacks Equity Research
Tale of the Tape
Should Value Investors Buy USANA Health Sciences (USNA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
May 08, 2026
By Zacks Equity Research
Tale of the Tape
USANA Health Sciences (USNA) Q1 Earnings and Revenues Surpass Estimates
USANA Health (USNA) delivered earnings and revenue surprises of +38.64% and +3.83%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
May 06, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
USANA Health Sciences, Inc. (USNA) held its Q1 2026 earnings call, discussing financial performance and key business updates. Specific financial metrics were not provided in the excerpt.
Why It Matters
The Q1 2026 earnings call provides insights into USANA's financial performance, growth strategies, and market position, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
USANA Health Sciences reported Q1 2026 net sales of $250 million, unchanged from Q1 2025. Net earnings fell to $7.5 million, with diluted EPS at $0.41, down from $0.49. Adjusted EBITDA was $28.4 million.
Why It Matters
USANA's stagnant sales and declining earnings suggest potential challenges in growth and profitability, affecting investor confidence and future stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
USANA Health Sciences (USNA) reported Q3 earnings of $0.61 per share, surpassing the Zacks estimate of $0.44, but down from $0.73 per share in the same quarter last year.
Why It Matters
USANA's earnings beat expectations, indicating strong performance and potential growth. However, the year-over-year decline may raise concerns about future profitability.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
USANA Health Sciences (NYSE: USNA) has been recognized in the 2026 USA TODAY Top Workplaces award list for its strong people-first culture, highlighting its workplace environment.
Why It Matters
USANA Health Sciences' recognition as a top workplace enhances its brand reputation, potentially attracting talent and improving employee satisfaction, which can drive productivity and profitability.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
USANA Health Sciences' CEO Kevin Guest emphasizes the impact of a genuine smile on business and life during National Show Your Smile Month in May.
Why It Matters
USANA Health Sciences emphasizes positive corporate culture, potentially enhancing employee morale and customer engagement, which can drive growth and profitability, impacting share performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
USANA Health Sciences has launched Glow, its first skin supplement aimed at improving skin health from within. This marks a new direction for the company in skincare products.
Why It Matters
USANA's launch of Glow™ diversifies its product line and taps into the skincare market, potentially boosting revenue and attracting new customers, impacting stock performance positively.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About USNA Stock
What is Usana Health Sciences, Inc.'s (USNA) stock forecast for 2026?
Based on our analysis of 4 Wall Street analysts, Usana Health Sciences, Inc. (USNA) has a median price target of $39.00. The highest price target is $39.00 and the lowest is $39.00.
Is USNA stock a good investment in 2026?
Analyst ratings for USNA are not currently available. The stock is currently trading at $18.96. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for USNA stock?
Wall Street analysts predict USNA stock could reach $39.00 in the next 12 months. This represents a 105.7% increase from the current price of $18.96. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Usana Health Sciences, Inc.'s business model?
The company operates a direct selling model, which allows it to market its products while empowering entrepreneurs globally. This model enables Usana to reach a wide customer base and generate revenue through the sale of its high-quality vitamins, dietary supplements, and personal care items.
What is the highest forecasted price for USNA Usana Health Sciences, Inc.?
The highest price target for USNA is $39.00 from at , which represents a 105.7% increase from the current price of $18.96.
What is the lowest forecasted price for USNA Usana Health Sciences, Inc.?
The lowest price target for USNA is $39.00 from at , which represents a 105.7% increase from the current price of $18.96.
What is the overall USNA consensus from analysts for Usana Health Sciences, Inc.?
Analyst ratings for USNA are not currently available. The stock is trading at $18.96.
How accurate are USNA stock price projections?
Stock price projections, including those for Usana Health Sciences, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 9, 2026 4:09 AM UTC